Omniox Stock

omniox.comHealthcare / BioTech & PharmaFounded: 2006Funding to Date: $87.65MM

Omniox is a provider of biotherapeutics for ischemic, hypoxic, and anemic diseases in oncology, cardiovascular and stroke diseases, diabetes, trauma, surgery, and sickle cell crises with a focused on overcoming biochemical shortcomings in prior efforts at oxygen and nitric oxide delivery.

Register for Details

For more details on financing and valuation for Omniox, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Omniox.

Register Today

Team

Management Team

Michael Marletta Ph.D
Co-Founder & Chairman
Stephen Cary Ph.D
Co-Founder, Chief Executive Officer & Board Member
Jonathan Winger Ph.D
Founder & Vice President, Process Development and New Product Introduction

Board Members

Jeffrey Samberg
Acadia Woods Partners
Ajit Shah Ph.D
Michael Marletta Ph.D
John Wesley

Other companies like Omniox in the BioTech & Pharma sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$8.84B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$4.74B